Pharmacokinetics, tissue distribution, and excretion of Korean Red ginseng components using radioisotopes in a rat model

[1]  D. Oh,et al.  Complete conversion of all typical glycosylated protopanaxatriol ginsenosides to aglycon protopanaxatriol by combined bacterial β-glycosidases , 2018, AMB Express.

[2]  Bi-hong Hong,et al.  A Study of 11-[3H]-Tetrodotoxin Absorption, Distribution, Metabolism and Excretion (ADME) in Adult Sprague-Dawley Rats , 2017, Marine drugs.

[3]  Dong-Hyun Kim.  Gut microbiota-mediated pharmacokinetics of ginseng saponins , 2017, Journal of ginseng research.

[4]  Xinya Duan,et al.  Anticancer effects of ginsenoside Rg3 (Review). , 2017, International journal of molecular medicine.

[5]  W. Setzer,et al.  Ginsenoside Rb1 as a neuroprotective agent: A review , 2016, Brain Research Bulletin.

[6]  J. Wan,et al.  Anticancer Activities of Protopanaxadiol- and Protopanaxatriol-Type Ginsenosides and Their Metabolites , 2016, Evidence-based complementary and alternative medicine : eCAM.

[7]  Ming-qing Li,et al.  The antitumor activity study of ginsenosides and metabolites in lung cancer cell. , 2016, American journal of translational research.

[8]  Seong-eun Park,et al.  Biotransformation of major ginsenosides in ginsenoside model culture by lactic acid bacteria , 2015, Journal of ginseng research.

[9]  Min-Jung Seo,et al.  Ginsenoside Rg1 suppresses early stage of adipocyte development via activation of C/EBP homologous protein-10 in 3T3-L1 and attenuates fat accumulation in high fat diet-induced obese zebrafish , 2015, Journal of ginseng research.

[10]  Deok-Chun Yang,et al.  Biosynthesis and biotechnological production of ginsenosides. , 2015, Biotechnology advances.

[11]  Sang Myung Lee,et al.  Characterization of Korean Red Ginseng (Panax ginseng Meyer): History, preparation method, and chemical composition , 2015, Journal of ginseng research.

[12]  Hyuck-Jai Choi,et al.  Anti-stress effects of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol in immobilized mice. , 2015, Biological & pharmaceutical bulletin.

[13]  S. Kwon,et al.  Chemical diversity of ginseng saponins from Panax ginseng☆ , 2015, Journal of ginseng research.

[14]  Shuying Liu,et al.  Chemical and antihyperglycemic activity changes of ginseng pectin induced by heat processing. , 2014, Carbohydrate polymers.

[15]  J. Ro,et al.  20(S)-Protopanaxatriol inhibits release of inflammatory mediators in immunoglobulin E-mediated mast cell activation , 2014, Journal of ginseng research.

[16]  H. Zhai,et al.  Effects of Ginsenoside Rg1 on the Expression of Toll-Like Receptor 3, 4 and Their Signalling Transduction Factors in the NG108-15 Murine Neuroglial Cell Line , 2014, Molecules.

[17]  Jong-Hoon Kim,et al.  A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases , 2014, Journal of ginseng research.

[18]  Hyung-Ki Kim.  Pharmacokinetics of ginsenoside Rb1 and its metabolite compound K after oral administration of Korean Red Ginseng extract , 2013, Journal of ginseng research.

[19]  Q. Wang,et al.  Different pharmacokinetics of the two structurally similar dammarane sapogenins, protopanaxatriol and protopanaxadiol, in rats. , 2013, Fitoterapia.

[20]  Dong Hyun Kim,et al.  Ginseng in Traditional Herbal Prescriptions , 2012, Journal of ginseng research.

[21]  Meng Chen,et al.  Panax notoginseng and its components decreased hypertension via stimulation of endothelial-dependent vessel dilatation. , 2012, Vascular pharmacology.

[22]  Hui Wang,et al.  Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure–Activity Relationships, and Molecular Mechanisms of Action , 2012, Front. Pharmacol..

[23]  J. Wan,et al.  Comparative study on saponin fractions from Panax notoginseng inhibiting inflammation-induced endothelial adhesion molecule expression and monocyte adhesion , 2011, Chinese medicine.

[24]  C. Leung,et al.  20(S)-Protopanaxadiol, a metabolite of ginsenosides, induced cell apoptosis through endoplasmic reticulum stress in human hepatocarcinoma HepG2 cells. , 2011, European journal of pharmacology.

[25]  Yan Wu,et al.  North American ginseng protects the heart from ischemia and reperfusion injury via upregulation of endothelial nitric oxide synthase. , 2011, Pharmacological research.

[26]  N. Gu,et al.  Ginsenoside Rg1 Enhances Endothelial Progenitor Cell Angiogenic Potency and Prevents Senescence In Vitro , 2011, The Journal of international medical research.

[27]  Zhi Wang,et al.  Ginsenoside Rb1 prevents homocysteine-induced endothelial dysfunction via PI3K/Akt activation and PKC inhibition. , 2011, Biochemical pharmacology.

[28]  J. Chen,et al.  Development of a UPLC-ESI-MS/MS Assay for 20(S)-Protopanaxadiol and Pharmacokinetic Application of Its Two Formulations in Rats , 2010, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[29]  Sun-Mee Lee,et al.  The effects of ginseng total saponin, panaxadiol and panaxatriol on ischemia/reperfusion injury in isolated rat heart. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[30]  Xiumei Gao,et al.  Absorption and Disposition of Ginsenosides after Oral Administration of Panax notoginseng Extract to Rats , 2009, Drug Metabolism and Disposition.

[31]  L. Sheng,et al.  Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: application of pharmacokinetic study in rats. , 2008, Journal of pharmaceutical and biomedical analysis.

[32]  Sung Dae Kim,et al.  Protopanaxadiol modulates LPS-induced inflammatory activity in murinemacrophage RAW264.7 cells , 2006 .

[33]  Z. Cai,et al.  In vivo rat metabolism and pharmacokinetic studies of ginsenoside Rg3. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[34]  M. Schubert-Zsilavecz,et al.  Degradation of ginsenosides in humans after oral administration. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[35]  Xiao-ling Fang,et al.  Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats. , 2003, Journal of ethnopharmacology.

[36]  E. Perry,et al.  Non‐ginsenoside nicotinic activity in ginseng species , 1999, Phytotherapy research : PTR.

[37]  Y. Benno,et al.  Role of Human Intestinal Prevotella oris in Hydrolyzing Ginseng Saponins , 1997, Planta medica.

[38]  Y. Yoo,et al.  Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. , 1995, Biological & pharmaceutical bulletin.

[39]  T. Miyase,et al.  Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside-Rb1 and -Rb2 in the digestive tract of rats. , 1991, Chemical & pharmaceutical bulletin.

[40]  M. Nagai,et al.  Chemical Studies on the Oriental Plant Drugs. XXVIII. Saponins and Sapogenins of Ginseng : Stereochemistry of the Sapogenin of Ginsenosides-Rb1, -Rb2 and -Rc , 1972 .

[41]  Guo-ping Yang,et al.  A review of biotransformation and pharmacology of ginsenoside compound K. , 2015, Fitoterapia.

[42]  Lars P Christensen,et al.  Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. , 2009, Advances in food and nutrition research.

[43]  Jae-Kwan Hwang,et al.  Ginsenoside 20(S)-Protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor γ (PPARγ) in 3T3-L1 adipocytes , 2006 .

[44]  刘勇,et al.  Metabolism and pharmacokinetics of ginsenosides , 2006 .